
Calici is an AI-driven company focused on accelerating drug and functional material discovery. Their core offering is Pharmaco-Net, a web-based cloud platform powered by protein tertiary structure analysis and evolutionary AI algorithms. Pharmaco-Net enables users to quickly identify drug candidates by searching docking sites and predicting binding energies, with results applicable to real experiments. The company leverages over 20 years of experience in protein 3D structures to refine data and create valuable learning datasets. Calici aims to provide better treatment options for patients and create a safer society through innovation in AI and protein structures. They have achieved key milestones such as securing their first North American export client, forming global compound supply partnerships, and being recognized as a "2024 ICT GROWTH Future Unicorn Company".

Calici is an AI-driven company focused on accelerating drug and functional material discovery. Their core offering is Pharmaco-Net, a web-based cloud platform powered by protein tertiary structure analysis and evolutionary AI algorithms. Pharmaco-Net enables users to quickly identify drug candidates by searching docking sites and predicting binding energies, with results applicable to real experiments. The company leverages over 20 years of experience in protein 3D structures to refine data and create valuable learning datasets. Calici aims to provide better treatment options for patients and create a safer society through innovation in AI and protein structures. They have achieved key milestones such as securing their first North American export client, forming global compound supply partnerships, and being recognized as a "2024 ICT GROWTH Future Unicorn Company".